UNDERSTANDING THE ROLE OF EXCESS BODY WEIGHT IN THE DEVELOPMENT OF TYPE 2 DIABETES MELLITUS

Excess body weight plays a pivotal role in the global surge of Type 2 Diabetes Mellitus (T2DM), a metabolic disorder characterized by insulin resistance and the body's inability to regulate glucose levels effectively. This paper delves into the complex pathophysiological mechanisms connecting excess body weight to T2DM, including adipose tissue dysfunction, inflammation, and insulin resistance, while also considering the role of metabolic syndrome and gut microbiota. The growing body of epidemiological evidence is discussed, alongside clinical and pharmacological interventions such as weight loss, which has been shown to significantly reduce the risk of T2DM. Finally, the paper explores global public health strategies, including policy interventions, aimed at addressing this epidemic by targeting obesity as a modifiable risk factor.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-24
DOI
https://doi.org/10.5281/zenodo.14550361
Primary Topic
Adipokines, Inflammation, and Metabolic Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UNDERSTANDING THE ROLE OF EXCESS BODY WEIGHT IN THE DEVELOPMENT OF TYPE 2 DIABETES MELLITUS

Zenodo (CERN European Organization for Nuclear Research)
Adipokines, Inflammation, and Metabolic Diseases
article

UNDERSTANDING THE ROLE OF EXCESS BODY WEIGHT IN THE DEVELOPMENT OF TYPE 2 DIABETES MELLITUS

article en

Abstract

Excess body weight plays a pivotal role in the global surge of Type 2 Diabetes Mellitus (T2DM), a metabolic disorder characterized by insulin resistance and the body's inability to regulate glucose levels effectively. This paper delves into the complex pathophysiological mechanisms connecting excess body weight to T2DM, including adipose tissue dysfunction, inflammation, and insulin resistance, while also considering the role of metabolic syndrome and gut microbiota. The growing body of epidemiological evidence is discussed, alongside clinical and pharmacological interventions such as weight loss, which has been shown to significantly reduce the risk of T2DM. Finally, the paper explores global public health strategies, including policy interventions, aimed at addressing this epidemic by targeting obesity as a modifiable risk factor.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 47%
Adipokines, Inflammation, and Metabolic Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.